Tempo: 150.0

Novo Nordisk is shipping more introductory doses of its blockbuster weight-loss drug Wegovy in the US as it grapples with supply constraints and competition from Eli Lilly & Co. CEO Lars Fruergaard Jorgensen says the company will continue to ramp up supply of its popular weight-loss drug "gradually." He spoke with Bloomberg's Katie Greifeld and Romaine Bostick. 

<p>Novo Nordisk is shipping more introductory doses of its blockbuster weight-loss drug Wegovy in the US as it grapples with supply constraints and competition from Eli Lilly &amp; Co. CEO Lars Fruergaard Jorgensen says the company will continue to ramp up supply of its popular weight-loss drug "gradually." He spoke with Bloomberg's Katie Greifeld and Romaine Bostick. </p>

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics and entertainment.

<p>Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics and entertainment.</p>

Listen to top interviews from Bloomberg News.

Bloomberg Talks

Novo Nordisk CEO Talks Weight Loss Drug Supply

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/7a30995e-df80-4f8d-b9d2-b164014b2e58/transcript

Advertisement